NEW YORK (GenomeWeb) – The Open Medicine Foundation (OMF) announced today that it has committed $1.2 million to fund the first year of operations at the newly established ME/CFS Collaborative Research Center at Stanford University.
According to the OMF, the center is focused on investigating the molecular basis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), as well as developing new diagnostics and treatments for the conditions. Its initial projects involve sequencing single T cells to understand the immunological basis of ME/CFS; analyzing sets of genomic and other omics data to define patient subgroups, uncover disease biomarkers, and identify potential drug targets; and developing a blood-based ME/CFS diagnostic that can also be used as a reporter in drug screening.
The OMF added that the ME/CFS Collaborative Research Center is being led by Stanford's Ron Davis and includes investigators from the Stanford Genome Technology Center, Yale University, Massachusetts General Hospital, Integrative Bioinformatics, the European Molecular Biology Laboratory, and the University of California, San Diego.